2018-2023 Global Osteosarcoma Market Report (Status and Outlook)

August 2018 | 116 pages | ID: 2E47B82A4CEEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Osteosarcoma market for 2018-2023.

An osteosarcoma (OS) is a cancerous tumor in a bone. Specifically, it is an aggressive malignant neoplasm that arises from primitive transformed cells of mesenchymal origin (and thus a sarcoma) and that exhibits osteoblastic differentiation and produces malignant osteoid. Osteosarcoma is the most common histological form of primary bone cancer. It is most prevalent in teenagers and young adults.
Osteosarcoma is the eighth-most common form of childhood cancer, comprising 2.4% of all malignancies in pediatric patients, and about 20% of all primary bone cancers. Incidence rates for osteosarcoma in U.S. patients under 20 years of age are estimated at 5.0 per million per year in the general population, with a slight variation between individuals of black, Hispanic, and white ethnicities (6.8, 6.5, and 4.6 per million per year, respectively). It is slightly more common in males (5.4 per million per year) than in females (4.0 per million per year).
Over the next five years, LPI(LP Information) projects that Osteosarcoma will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Osteosarcoma market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

• Intramedullary Osteosarcoma
• Juxtacortical Osteosarcoma

Segmentation by application:

• Hospital & Clinics
• Cancer Research Institutes

We can also provide the customized separate regional or country-level reports, for the following regions:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• Pfizer
• Spectrum Pharmaceuticals
• Hikma Pharmaceuticals
• Baxter
• Isofol
• Advaxis
• Bellicum Pharmaceuticals
• Novartis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Osteosarcoma market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Osteosarcoma market by identifying its various subsegments.
• Focuses on the key global Osteosarcoma players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Osteosarcoma with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the size of Osteosarcoma submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Osteosarcoma Market Size 2013-2023
  2.1.2 Osteosarcoma Market Size CAGR by Region
2.2 Osteosarcoma Segment by Type
  2.2.1 Intramedullary Osteosarcoma
  2.2.2 Juxtacortical Osteosarcoma
  2.2.3 Extra-Skeletal Osteosarcoma
2.3 Osteosarcoma Market Size by Type
  2.3.1 Global Osteosarcoma Market Size Market Share by Type (2013-2018)
  2.3.2 Global Osteosarcoma Market Size Growth Rate by Type (2013-2018)
2.4 Osteosarcoma Segment by Application
  2.4.1 Hospital & Clinics
  2.4.2 Cancer Research Institutes
2.5 Osteosarcoma Market Size by Application
  2.5.1 Global Osteosarcoma Market Size Market Share by Application (2013-2018)
  2.5.2 Global Osteosarcoma Market Size Growth Rate by Application (2013-2018)

3 GLOBAL OSTEOSARCOMA BY PLAYERS

3.1 Global Osteosarcoma Market Size Market Share by Players
  3.1.1 Global Osteosarcoma Market Size by Players (2016-2018)
  3.1.2 Global Osteosarcoma Market Size Market Share by Players (2016-2018)
3.2 Global Osteosarcoma Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 OSTEOSARCOMA BY REGIONS

4.1 Osteosarcoma Market Size by Regions
4.2 Americas Osteosarcoma Market Size Growth
4.3 APAC Osteosarcoma Market Size Growth
4.4 Europe Osteosarcoma Market Size Growth
4.5 Middle East & Africa Osteosarcoma Market Size Growth

5 AMERICAS

5.1 Americas Osteosarcoma Market Size by Countries
5.2 Americas Osteosarcoma Market Size by Type
5.3 Americas Osteosarcoma Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Osteosarcoma Market Size by Countries
6.2 APAC Osteosarcoma Market Size by Type
6.3 APAC Osteosarcoma Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Osteosarcoma by Countries
7.2 Europe Osteosarcoma Market Size by Type
7.3 Europe Osteosarcoma Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Osteosarcoma by Countries
8.2 Middle East & Africa Osteosarcoma Market Size by Type
8.3 Middle East & Africa Osteosarcoma Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL OSTEOSARCOMA MARKET FORECAST

10.1 Global Osteosarcoma Market Size Forecast (2018-2023)
10.2 Global Osteosarcoma Forecast by Regions
  10.2.1 Global Osteosarcoma Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Osteosarcoma Forecast by Type
10.8 Global Osteosarcoma Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Pfizer
  11.1.1 Company Details
  11.1.2 Osteosarcoma Product Offered
  11.1.3 Pfizer Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Pfizer News
11.2 Spectrum Pharmaceuticals
  11.2.1 Company Details
  11.2.2 Osteosarcoma Product Offered
  11.2.3 Spectrum Pharmaceuticals Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Spectrum Pharmaceuticals News
11.3 Hikma Pharmaceuticals
  11.3.1 Company Details
  11.3.2 Osteosarcoma Product Offered
  11.3.3 Hikma Pharmaceuticals Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Hikma Pharmaceuticals News
11.4 Baxter
  11.4.1 Company Details
  11.4.2 Osteosarcoma Product Offered
  11.4.3 Baxter Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Baxter News
11.5 Isofol
  11.5.1 Company Details
  11.5.2 Osteosarcoma Product Offered
  11.5.3 Isofol Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Isofol News
11.6 Advaxis
  11.6.1 Company Details
  11.6.2 Osteosarcoma Product Offered
  11.6.3 Advaxis Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Advaxis News
11.7 Bellicum Pharmaceuticals
  11.7.1 Company Details
  11.7.2 Osteosarcoma Product Offered
  11.7.3 Bellicum Pharmaceuticals Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
  11.7.4 Main Business Overview
  11.7.5 Bellicum Pharmaceuticals News
11.8 Novartis
  11.8.1 Company Details
  11.8.2 Osteosarcoma Product Offered
  11.8.3 Novartis Osteosarcoma Revenue, Gross Margin and Market Share (2016-2018)
  11.8.4 Main Business Overview
  11.8.5 Novartis News

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Table Product Specifications of Osteosarcoma
Figure Osteosarcoma Report Years Considered
Figure Market Research Methodology
Figure Global Osteosarcoma Market Size Growth Rate 2013-2023 ($ Million